Medical Device News Magazine

ACC Middle East 2022 Together with 13th Emirates Cardiac Society Congress to Highlight Emerging Trends, Contemp

The American College of Cardiology

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

The American College of Cardiology and Emirates Cardiac Society will host ACC Middle East 2022 Together with 13th Emirates Cardiac Society Congress in Dubai, United Arab Emirates, from October 7-9, 2022.

The annual conference will bring together cardiac care teams in the Middle East region with global cardiovascular experts to examine emerging trends, evidence-based strategies and contemporary best practices for the prevention and management of cardiovascular disease.

“The annual Emirates Cardiac Society congress is one of the biggest meetings in the region. This year we are proud to partner with the ACC for the third time to produce a state-of-the-art conference,” said Wael A. Almahmeed, MD, FACC, UAE Vice Chair of the conference and a consultant cardiologist at the Heart and Vascular Institute at Cleveland Clinic Abu Dhabi. “We have five tracks covering all the subspecialties of cardiology and including the latest in late-breaking science.”

Khaled M. Ziada, MD, FACC, and Wael A. Almahmeed, MD, FACC, will serve as Vice Chairs for the conference. Valentin Fuster, MD, PhD, MACC, editor-in-chief of the Journal of the American College of Cardiology, will present the Opening Plenary Session, “Role of Imagenomics in Enhancing Cardiovascular Health Throughout the Lifespan.” Other plenaries will focus on the following key topics:

  • Top Takeaways From the Latest Guidelines: Chest Pain and Coronary Revascularization
  • The Highlights of the 2022 ACC/AHA/HFSA Guidelines For Management of Heart Failure
  • Lipid Lowering Therapy Beyond Statins
  • Artificial Intelligence in Cardiology

All attendees will have access to the interactive learning lab, featuring a hands-on echo simulation, challenging clinical case discussions, Heart Songs 5, ECG Drill & Practice, and more.

Contact Katie Glenn at kglenn@acc.org to receive embargoed copies of the abstracts or apply for media credentials. All posters are embargoed until Monday, October 3, 2022, at 12 a.m. ET/8 a.m. Gulf Standard Time. Below is a selection of posters being presented at the conference:

  • Ivabradine effects on COVID-19 induced postural orthostatic tachycardia syndrome
  • Do Middle Eastern Women with Atrial Fibrillation Have Worse Baseline Clinical Profiles and One-Year Cardiovascular [Events] Compared with Men? The Jordan Atrial Fibrillation Study
  • Impact of the Morning vs. Evening Dosing of Antihypertensive Drugs on 24 Hour Ambulatory Blood Pressure
  • The effect of lavender aromatherapy on anxiety reduction in cardiovascular patients: a systematic review and meta-analysis of randomized controlled trials
  • Association of grain intake and premature coronary artery disease: Iranian Premature Coronary Artery Disease Study

To learn more about the conference visit ACC.org/MiddleEast2022.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”